GlassScriptPhysician profile
Allison Leigh Smith
NPI 1699791657
$1,905.16
in general payments reported to CMS, 2019-2025
25 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $390 · 2022: $409 · 2023: $558 · 2024: $321 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,106.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $337.19 | 2021-2025 | |
| Astellas Pharma US INC | $177.37 | 2024-2025 | Veozah |
| Pfizer INC. | $137.62 | 2022-2024 | |
| Exeltis, USA INC. | $136.08 | 2021-2024 | Slynd |
| Sumitomo Pharma America, INC. | $132.42 | 2023-2025 | Myfembree, Gemtesa |
| Daiichi Sankyo INC. | $114.79 | 2021-2023 | Injectafer |
| Hologic Sales and Service, LLC | $112.02 | 2023-2024 | Thinprep 2000 Processor, Aptima, Fluent Fluid Management System |
| Bayer Healthcare Pharmaceuticals INC. | $96.14 | 2023-2025 | |
| Osprey Medical INC | $95.24 | 2021 | |
| Myovant Sciences INC. | $88.92 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $73.04 | 2021-2023 | |
| Exact Sciences Corporation | $58.30 | 2023-2024 | Cologuard Collection Kit |
| Evofem Biosciences, INC. | $48.93 | 2021-2022 | |
| Organon LLC | $48.69 | 2022-2025 | Nexplanon |
| Baxter Healthcare | $39.71 | 2024 | Perclot |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $36.78 | 2022-2023 | |
| Axonics, INC. | $34.66 | 2023 | Axonics |
| Seagen INC. | $25.46 | 2023 | Tivdak |
| Smith+Nephew, INC. | $21.65 | 2025 | Pico, Renasys Touch |
| Agile Therapeutics, INC. | $17.97 | 2023 | Twirla |
| Ascend Therapeutics US, LLC | $15.64 | 2024 | |
| Coopersurgical, INC. | $14.90 | 2021 | |
| Lupin INC. | $14.73 | 2021 | |
| Shield Therapeutics INC | $14.17 | 2023 | Accrufer |
| Avion Pharmaceuticals | $12.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.